Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant

Jeannete Zurita,Gabriela Sevillano,María Belén Solís,Ariane Paz y Miño,Beatriz Rizkallah Alves,Jessica Changuan,Pablo González
DOI: https://doi.org/10.1016/j.jgar.2024.07.003
IF: 4.349
2024-07-18
Journal of Global Antimicrobial Resistance
Abstract:Background In Ecuador, data on molecular epidemiology, as well as circulating clones, are limited. Therefore, this study aims to know the population structure of Pseudomonas aeruginosa by identifying clones in clinical samples in Quito-Ecuador. Methods A significant set (45) clinical Pseudomonas aeruginosa isolates were selected, including multidrug and non-multidrug resistant isolates, which were assigned to sequence types (STs) and compared with their antibiotic susceptibility profile. The genetic diversity was assessed by applying the multilocus sequence typing (MLST) scheme and the genetic relationships between different STs were corroborated by phylogenetic networks. Results The MLST analysis identified 24 different STs and the most prevalent STs were ST-3750 and ST-253. The majority of the multidrug-resistance (MDR) isolates were included in ST-3750 and ST-253, also 3 singleton STs were identified as MDR isolates. The 21 different STs were found in non-multidrug resistance (non-MDR) isolates, and only 3 STs were found in more the one isolate. Conclusions The population structure of clinical P. aeruginosa present in these isolates indicates a significant association between MDR isolates and the clonal types: all ST-3750 and ST-253 isolates were MDR. ST-3750 is a closely related strain to the clonal complex ST111 (CC111). ST-253 and ST111 are a group of successful high-risk clones widely distributed worldwide. The multiresistant isolates studied are grouped in the most prevalent sequence types found, and the susceptible isolates correspond mainly to singleton sequence types. Therefore, these high-risk clones and their association with multidrug-resistance phenotypes are contributing to the spread of MDR in Quito-Ecuador.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?